eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. Please read our Terms of Service before submitting your own eLetter.
ReportsHIV
A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection
- View ORCID ProfileMichael C. Sneller1,
- J. Shawn Justement1,
- Kathleen R. Gittens2,
- Mary E. Petrone1,
- View ORCID ProfileKatherine E. Clarridge1,
- View ORCID ProfileMichael A. Proschan3,
- Richard Kwan2,
- Victoria Shi1,
- View ORCID ProfileJana Blazkova1,
- View ORCID ProfileEric W. Refsland1,
- View ORCID ProfileDaryl E. Morris4,
- View ORCID ProfileKristen W. Cohen4,
- View ORCID ProfileM. Juliana McElrath4,5,
- View ORCID ProfileRong Xu6,
- Michael A. Egan6,
- John H. Eldridge6,
- Erika Benko7,
- Colin Kovacs7,8,
- Susan Moir1,
- View ORCID ProfileTae-Wook Chun1,*,† and
- Anthony S. Fauci1,*
- 1Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA.
- 2Critical Care Medicine Department, Clinical Center, NIH, Bethesda, MD 20892, USA.
- 3Biostatistics Research Branch, NIAID, NIH, Bethesda, MD 20892, USA.
- 4Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
- 5Department of Global Health, University of Washington, Seattle, WA 98195, USA.
- 6Profectus BioSciences Inc., Tarrytown, NY 10591, USA.
- 7Maple Leaf Medical Clinic, Toronto, Ontario M5G 1K2, Canada.
- 8Department of Medicine, University of Toronto, Toronto, Ontario M5S 1A1, Canada.
- ↵†Corresponding author. Email: twchun{at}nih.gov
↵* These authors contributed equally to this work.
See allHide authors and affiliations
Science Translational Medicine 06 Dec 2017:
Vol. 9, Issue 419, eaan8848
DOI: 10.1126/scitranslmed.aan8848
Vol. 9, Issue 419, eaan8848
DOI: 10.1126/scitranslmed.aan8848
Michael C. Sneller
1Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA.
J. Shawn Justement
1Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA.
Kathleen R. Gittens
2Critical Care Medicine Department, Clinical Center, NIH, Bethesda, MD 20892, USA.
Mary E. Petrone
1Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA.
Katherine E. Clarridge
1Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA.
Michael A. Proschan
3Biostatistics Research Branch, NIAID, NIH, Bethesda, MD 20892, USA.
Richard Kwan
2Critical Care Medicine Department, Clinical Center, NIH, Bethesda, MD 20892, USA.
Victoria Shi
1Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA.
Jana Blazkova
1Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA.
Eric W. Refsland
1Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA.
Daryl E. Morris
4Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Kristen W. Cohen
4Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
M. Juliana McElrath
4Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
5Department of Global Health, University of Washington, Seattle, WA 98195, USA.
Rong Xu
6Profectus BioSciences Inc., Tarrytown, NY 10591, USA.
Michael A. Egan
6Profectus BioSciences Inc., Tarrytown, NY 10591, USA.
John H. Eldridge
6Profectus BioSciences Inc., Tarrytown, NY 10591, USA.
Erika Benko
7Maple Leaf Medical Clinic, Toronto, Ontario M5G 1K2, Canada.
Colin Kovacs
7Maple Leaf Medical Clinic, Toronto, Ontario M5G 1K2, Canada.
8Department of Medicine, University of Toronto, Toronto, Ontario M5S 1A1, Canada.
Susan Moir
1Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA.
Tae-Wook Chun
1Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA.
Anthony S. Fauci
1Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA.
Submit a Response to This Article
No eLetters have been published for this article.